Mark your calendars! Electromed Inc. to Unveil First Quarter Fiscal 2025 Financial Results on November 12, 2024 at 5:00 PM ET

Exciting News from Electromed, Inc. Get Ready for the Big Announcement! Hey there, readers! Do we have some exciting news for you today! Electromed, Inc., a leading provider of innovative airway clearance technologies, has just announced that they will be releasing their financial results for the fiscal 2025 first quarter on November 12, 2024. If…

Read More

FDA Advisory Panel for IceCure’s Prosense Marketing Authorization Receives Overwhelming Public Response from Stakeholders

IceCure ProSense® Cryoablation System: A Game-Changer for Breast Cancer Treatment Exciting News from FDA Advisory Panel Exciting news has emerged from the FDA Advisory Panel regarding the De Novo marketing submission of the IceCure ProSense® Cryoablation System for early-stage low risk breast cancer. Scheduled for November 7, 2024, this panel will provide recommendations and vote…

Read More

Unlocking the Potential: The Growing Market for mRNA Synthesis Manufacturing – A Heartfelt Look into the Projected USD 2958.3 Million Industry by 2029, with a 5.8% CAGR – Insights from MarketsandMarkets

The Future of mRNA Synthesis and Manufacturing Delray Beach, FL, Oct. 29, 2024 (GLOBE NEWSWIRE) — The global mRNA synthesis and manufacturing market is projected to grow from USD 2,231.4 million in 2024 to USD 2,958.3 million by 2029, at a CAGR of 5.8%. Key drivers include the growing focus on mRNA-based vaccines, expanding therapeutic…

Read More

Revolutionizing Energy: Clean Energy Technologies Inc. and Exergy International Join Forces to Bring ORC Heat Recovery Solutions to the Americas

Clean Energy Technologies, Inc. Signs MOU with Exergy International Srl Irvine, CA., Oct. 29, 2024 (GLOBE NEWSWIRE) Clean Energy Technologies, Inc. (“CETY”) (Nasdaq: CETY), a clean energy manufacturing and services company specializing in eco-friendly energy solutions, clean fuels, and alternative power for small and mid-sized projects in Americas, Europe, and Asia, has signed a Memorandum…

Read More

Unleashing the Power of Intelligence: Intelligent Bio Solutions Reports Impressive First Quarter Revenue for Fiscal 2025

Intelligent Bio Solutions Inc. Reports Strong Quarterly Revenue Growth New York, Oct. 29, 2024 Intelligent Bio Solutions Inc. (Nasdaq: INBS) has recently announced promising unaudited revenue results for the fiscal first quarter ended September 30, 2024. The company reported a 10% year-on-year increase and a 20% quarter-on-quarter increase in revenue, totaling approximately $0.87 million for…

Read More

Frontier Airlines Soars to Success: A Playful Peek at their Third Quarter 2024 Financial Results!

Frontier Group Holdings, Inc. Reports Strong Financial Results Denver, Oct. 29, 2024 /PRNewswire/ Financial Highlights: Total operating revenues for the third quarter of 2024 reached $935 million, showing a 6 percent increase compared to the same period in 2023. This growth was driven by a 4 percent increase in capacity, showcasing Frontier Group Holdings, Inc.’s…

Read More

Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Biora Therapeutics Announces Stock Offering Introduction SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 745,342 shares of the Company’s common stock at an offering price of $4.025 per share…

Read More